Dr Al-Jamal’s team focuses on engineering novel nanomaterials for biomedical applications. She has a multidisciplinary team, who are working on developing novel nanomedicines for combinatory therapy and theranostic applications.

To design and develop smart (stimuli-responsive) vectors to improve gene and anticancer therapy, besides introducing new targeting approaches to enhance efficacy and to reduce the side effects of existing chemotherapeutics.

Explore new methodologies, such as microfluidics, to fabricate and scale-up multifunctional nanoparticles for combinatory therapy, immunotherapy or theranostic applications.